NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease

RecruitingN/A

Sponsor: Tianjin Medical University

Conditions: Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism

Interventions: Diagnostic Test: 18F-FPyCO/SMBT-1

Countries: China

To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.

Eligibility overview

Sex: ALL

Age: 18 Years to 90 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated PD (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled TSPO PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria:

* patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Locations (2)

Hefei, Anhui, China
Tianjin, Tian, China